Labs / Assays & in vitro testing
CDI Labs
Baltimore, MD, United States · cdilabs.com
GLP · GMP
CDI Labs is a specialized CRO and lab services company focused on proteomics, autoantibody profiling, biomarker discovery, target identification, and related antibody specificity work. It serves academic and industry customers from sites in Mayagüez, Puerto Rico and Baltimore, Maryland, with operations also listed in Toronto, Canada. The company supports research across autoimmune disease, oncology, neurological disease, infectious disease, and genetic disease.
Their website has a general contact form; we send your quote request through it.
What they offer
HuProt™ Services
Uses a human proteome microarray with 21,000+ full-length proteins for autoantibody profiling and target ID.
VirScan® PhIP-Seq Services
Profiles antibodies against known vertebrate viral proteomes using phage display immunoprecipitation sequencing.
VirScan® Exposome PhIP-Seq Services
Profiles antibody responses against non-human allergen and other exposome protein sequences.
HuScan® PhIP-Seq Services
Performs epitope-level autoantibody profiling against the human proteome with quantitative sequencing readouts.
MouseScan™ PhIP-Seq Services
Performs epitope-level autoantibody profiling against the murine proteome for preclinical samples.
Peptide Hormone Services
Offers peptide hormone-related services as part of the service platform lineup.
Pan-isotype Profiling Services
Profiles antibody responses across isotypes.
Molecular Glue Discovery
Supports discovery of ternary complex interactions using the HuGlue® technology access program.
Custom PhIP-Seq Libraries
Develops custom phage immunoprecipitation sequencing libraries for tailored antibody profiling studies.
Biomarker Discovery
Supports discovery of biomarkers from autoantibody and proteomic data.
Patient Stratification
Helps stratify patients using biomarker and antibody profiling data.
Patient Response / Adverse Reaction Prediction
Supports prediction of treatment response and adverse reactions.
Diagnostic Development
Supports development of diagnostic assays and workflows.
Vaccine Development and Safety
Supports vaccine-related immune profiling and safety studies.
Viral Exposure Profiling
Analyzes antibody histories to assess viral exposure.
Target ID Services
Identifies protein-protein and protein-nucleic acid interaction targets, including target deconvolution and discovery.
Antibody Development
Provides specialized CRO support for antibody development projects.
Antibody Pairs
Provides antibody pair development services.
Protein Production
Provides custom protein production services for downstream validation.
Immunogenicity Testing
Assesses immunogenicity for cell therapy, CRISPR-Cas9, and related modalities.
What they work on
- Modalities
- Small molecule, Antibody, ADC, Peptide, Oligonucleotide, Cell therapy, Gene editing, Recombinant protein, Vaccine
- Species and models
- human, mouse, murine, E. coli
- Assays and studies
- autoantibody profiling, biomarker discovery, target identification, target deconvolution, protein-protein interaction profiling, protein-nucleic acid interaction profiling, antibody specificity validation, post-translational modification specificity testing, viral exposure profiling, immunogenicity testing, pan-isotype profiling, epitope-level profiling, and 2 more
- Instruments and platforms
- HuProt™ microarray, HuScan® PhIP-Seq, VirScan® PhIP-Seq, MouseScan™ PhIP-Seq, fluorescence intensity measurements, Illumina sequencing
- Scale and capacity
- 21,000+ full-length human proteins, 48,921 human proteins and isoforms, 68,000+ viral protein sequences, 15,860+ non-human allergen protein sequences, 50,135 murine proteins and protein isoforms, 200,000+ compounds per screen
- Therapeutic areas
- autoimmune disease, oncology, neurological disease, infectious disease, genetic disease
- What to send
- peripheral serum · plasma · cerebrospinal fluid · tissue lysates · stool · saliva · synthesized sample · preclinical murine samples
- Type
- CRO
- Sites
- Mayagüez, Puerto Rico · Baltimore, United States · Toronto, Canada
- Quality
- GLP · GMP
- Serves
- Canada, Europe, Japan, China, United Kingdom
- Address
- 2026 Press Release CDI Labs' Dr Tyler Hulett Ph.D. joins global Cancer Grand Challenges team taking o
Similar labs. Sparx BIO, Aurigene Pharmaceutical Services, Bioklone Biotech Private Limited, Esco Aster
Found in a contract services directory. Listing built from cdilabs.com. Work here? Claim this listing.